HomeProductsBioactive CompoundsEpigeneticsPARPBasroparib
Chemical structure of CAS 1858179-75-5

Basroparib

CAS No.1858179-75-5
MDL No.N/A
MFC18H21F2N7O3
MW421.40
InChI KeyALDDPEMJJONRDI-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1858179-75-5
Product NameBasroparib

Associated Conditions

neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract.

European journal of cancer (Oxford, England : 1990) • Vol. 173 • 2022
PMID: 35849876DOI: 10.1016/j.ejca.2022.06.031

Targeting Wnt signaling in colon cancer stem cells.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 17, Issue 4 • 2011
PMID: 21159886DOI: 10.1158/1078-0432.CCR-10-1204

Linking colorectal cancer to Wnt signaling.

Cell • Vol. 103, Issue 2 • 2000
PMID: 11057903DOI: 10.1016/s0092-8674(00)00122-7

Pre-ovulatory and post-ovulatory overripeness.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics • Vol. 14, Issue 2 • 1976
PMID: 10198DOI: 10.1002/j.1879-3479.1976.tb00577.x

Documentation